Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients

Blood

Volumn 94, Issue 9, 1999, Pages 3135-3140

  Buzyn, Agnès ^a   Petit, Frederic ^b   Ostankovitch, Marina ^b   Figueiredo, Suzanne ^b   Varet, Bruno ^b   Guillet, Jean Gérard ^b   Ameisen, Jean Claude ^b   Estaquier, Jérôme ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKEMIA; LEUKEMIA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0033229712     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.9.3135.421k37_3135_3140     Document Type: Article

References (18)

1. Kolb H-J, Holler E: Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Immunol 9:139, 1997
2. Lynch D, Ramsdell F, Alderson M: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995
3. van Parijs L, Abbas A: Homeostasis and self tolerance in the immune system: Turning lymphocytes off. Science 280:243, 1998
4. Zeytun A, Hassuneh M, Nagarkatti M, Nagarkatti P: Fas-Fas Ligand-based interactions between tumor cells and tumor specific cytotoxic T lymphocytes: A lethal two-way street. Blood 90:1952, 1997
5. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075, 1996
6. Matzinger P: The JAM test: A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:348, 1991
7. Klas C, Debatin K-M, Jonker RR, Krammer PH: Activation interferes with APO-1 pathway in mature human T cells. Int Immunol 5:625, 1993
8. Nagata S: Fas Ligand and immune evasion. Nat Med 2:1306, 1996
9. Giralt SA, Champlin RE: Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 84:3603, 1994
10. Buzyn A, Belanger C, Audat F, Hermine O, Bodemer C, Ribrag V, Radford I, Poirel H, Chane C, Valensi F, Macintyre E, Varet B: Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantation. Br J Haematol 92:423, 1996
11. Faber LM, van der Hoeven J, Goulmy E, Hooftman-den Otter AL, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH: Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic lymphocytes. J Clin Invest 96:877, 1995
12. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C J: Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133:335, 1996
13. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J-C, Tschopp J: Melanoma cell expression of Fas (Apo-1/CD95) Ligand: Implications for tumor immune escape. Science 274:1363, 1996
14. Kiener PA, Davis P, Rankin B, Klebanoff S, Ledbetter J, Starling G, Liles W: Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation. J Immunol 159:1594, 1997
15. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348, 1995
16. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hakate K, Drummond A, Nagata S: Fas ligand in human serum. Nat Med 2:317, 1996
17. Tanaka M, Adachi M, Nagata S: Downregulation of Fas ligand by shedding. Nat Med 4:31, 1998
18. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas Ligand kills human peripheral blood T lymphocytes, and soluble Fas L blocks the killing. J Exp Med 186:2045, 1997